
Aptinyx APTX
Quartalsbericht 2023-Q1
hinzugefügt 18.05.2023
Aptinyx P/S 2011-2026 | APTX
P/S Jährlich Aptinyx
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 204 | 105 | 35.8 | 16.3 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 204 | 16.3 | 90.2 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Agenus
AGEN
|
0.00137 | $ 3.27 | -1.8 % | $ 1.17 M | ||
|
Agios Pharmaceuticals
AGIO
|
30.2 | $ 29.33 | -2.98 % | $ 1.7 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Akebia Therapeutics
AKBA
|
1.42 | $ 1.26 | -3.44 % | $ 324 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Alector
ALEC
|
11.7 | $ 2.26 | -7.2 % | $ 233 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Aligos Therapeutics
ALGS
|
9.03 | $ 7.02 | -0.21 % | $ 451 M | ||
|
Alkermes plc
ALKS
|
3.48 | $ 29.32 | -2.61 % | $ 4.83 B | ||
|
Allogene Therapeutics
ALLO
|
7.43 K | $ 2.57 | -7.73 % | $ 403 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
11 | $ 330.95 | -0.59 % | $ 43.4 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Altimmune
ALT
|
23.1 K | $ 4.2 | -2.55 % | $ 298 M | ||
|
ALX Oncology Holdings
ALXO
|
1.35 K | $ 2.11 | 0.09 % | $ 110 M | ||
|
Amgen
AMGN
|
5.4 | $ 387.85 | 0.03 % | $ 209 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 20.22 | -0.05 % | $ 945 M | ||
|
Amarin Corporation plc
AMRN
|
1.43 | $ 13.62 | -1.3 % | $ 5.55 B | ||
|
AIM ImmunoTech
AIM
|
143 | $ 0.92 | 5.25 % | $ 44.2 M | ||
|
AnaptysBio
ANAB
|
5.05 | $ 54.61 | -0.8 % | $ 1.55 B | ||
|
Anika Therapeutics
ANIK
|
2.24 | $ 14.44 | 0.53 % | $ 212 M | ||
|
ANI Pharmaceuticals
ANIP
|
1.95 | $ 75.31 | 1.91 % | $ 1.45 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Apellis Pharmaceuticals
APLS
|
2.76 | $ 20.53 | -2.05 % | $ 2.59 B | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.78 | -0.67 % | $ 4.25 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Aptevo Therapeutics
APVO
|
3.11 | $ 7.28 | -0.55 % | $ 2.01 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Aquestive Therapeutics
AQST
|
4.2 | $ 3.99 | -0.15 % | $ 346 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
2.83 | $ 8.11 | -1.44 % | $ 219 M | ||
|
Ardelyx
ARDX
|
3.98 | $ 6.32 | -3.54 % | $ 1.52 B | ||
|
argenx SE
ARGX
|
311 | $ 762.51 | -0.58 % | $ 25 B |